Volume 84, Issue 4, Pages (October 2013)

Slides:



Advertisements
Similar presentations
Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
Advertisements

Volume 70, Issue 1, Pages (July 2006)
Increased expression of heparanase in overt diabetic nephropathy
Inflammatory cytokines in acute renal failure
Volume 72, Issue 3, Pages (August 2007)
Volume 80, Issue 7, Pages (October 2011)
Volume 73, Issue 1, Pages 3-5 (January 2008)
Volume 92, Issue 3, Pages (September 2017)
Volume 87, Issue 4, Pages (April 2015)
Volume 76, Issue 1, Pages (July 2009)
Volume 78, Issue 4, Pages (August 2010)
Volume 93, Issue 1, Pages (January 2018)
Volume 74, Issue 10, Pages (November 2008)
Volume 79, Issue 9, Pages (May 2011)
Volume 85, Issue 5, Pages (May 2014)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 84, Issue 2, Pages (August 2013)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 92, Issue 1, Pages (July 2017)
Volume 82, Issue 12, Pages (December 2012)
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 69, Issue 1, Pages (January 2006)
Volume 84, Issue 5, Pages (November 2013)
Volume 87, Issue 2, Pages (February 2015)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 81, Issue 12, Pages (June 2012)
Volume 65, Issue 6, Pages (June 2004)
Victoria F. Norwood, Scott G. Morham, Oliver Smithies 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 85, Issue 1, Pages (January 2014)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6–/– Mouse Model of PXE  Jingyi Zhao, Joshua Kingman,
Volume 70, Issue 1, Pages (July 2006)
Volume 79, Pages S20-S23 (April 2011)
Volume 72, Issue 3, Pages (August 2007)
Growth hormone promotes glomerular lipid accumulation in bGH mice
Elevated Dietary Magnesium Prevents Connective Tissue Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)  Jennifer LaRusso, Qiaoli.
Volume 75, Issue 10, Pages (May 2009)
Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylase  Mutsuko Ohnishi, Teruyo.
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury  Richard A. Zager,
Volume 137, Issue 4, Pages (October 2009)
Volume 83, Issue 3, Pages (March 2013)
Volume 86, Issue 4, Pages (October 2014)
Volume 72, Issue 4, Pages (August 2007)
Volume 66, Issue 3, Pages (September 2004)
Volume 84, Issue 3, Pages (September 2013)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Growth and development alter susceptibility to acute renal injury
Prevention of mesangial sclerosis by bone marrow transplantation
Neil J. Paloian, Elizabeth M. Leaf, Cecilia M. Giachelli 
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 68, Issue 6, Pages (December 2005)
Volume 85, Issue 2, Pages (January 2014)
Volume 74, Issue 6, Pages (September 2008)
Volume 68, Issue 2, Pages (August 2005)
The hypothesis that bone turnover influences FGF23 secretion
Volume 85, Issue 1, Pages 3-4 (January 2014)
Circadian regulation of renal function
Volume 78, Issue 4, Pages (August 2010)
Fibrosis and renal aging
Volume 76, Issue 8, Pages (October 2009)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 82, Issue 10, Pages (November 2012)
Volume 80, Issue 10, Pages (November 2011)
Increased parathyroid expression of klotho in uremic rats
Volume 65, Issue 2, Pages (February 2004)
Volume 65, Issue 6, Pages (June 2004)
Marta Christov, Harald Jüppner  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Volume 79, Issue 11, Pages (June 2011)
Presentation transcript:

Volume 84, Issue 4, Pages 713-721 (October 2013) Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease  Shiqin Zhang, Ryan Gillihan, Nan He, Timothy Fields, Shiguang Liu, Troy Green, Jason R. Stubbs  Kidney International  Volume 84, Issue 4, Pages 713-721 (October 2013) DOI: 10.1038/ki.2013.194 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Effects of chronic phosphate restriction on calvarial fibroblast growth factor 23 (FGF23) gene and protein expression in Col4a3-null mice. (a) Graphical representation and statistical data of serum FGF23 levels for individual wild-type (WT) and Col4a3-null (KO) mice at 12 weeks demonstrating persistent elevation of serum FGF23 in KO mice consuming both a control diet and a 0.2% phosphate (phos) diet; conversely, many KO mice receiving the 0.02% diet demonstrated a marked suppression of serum FGF23 levels at 12 weeks. (b) Quantitative reverse transcription polymerase chain reaction was performed on calvaria from KO and WT mice at 12 weeks of age on all three diets. KO mice consuming a control diet exhibited an approximately twofold increase in FGF23 gene transcription compared with WT mice on the same diet (P=0.09). Severe dietary phosphate restriction in KO mice suppressed FGF23 gene expression to levels below those found in the WT mice on a similar diet (**P=0.001; n≥5 per group). (c) Representative images of western blot for FGF23 protein expression in calvaria from KO and WT mice receiving the control and 0.02% phosphate diets (two per group). (d) Quantification of calvarial FGF23 protein expression from western blot analysis demonstrates a marked reduction in FGF23 expression in KO mice consuming the 0.02% phosphate diet (*P<0.05; n=4 per group). NS, not significant. Kidney International 2013 84, 713-721DOI: (10.1038/ki.2013.194) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Phosphate-deficient diet prevents microcystic tubular injury in Col4a3-null mice. (a) Periodic acid–Schiff (PAS) staining of mid-sagittal kidney sections from Col4a3-null (KO) and wild-type (WT) mice on control, 0.2%, or 0.02% phosphate (phos) diets. KO mice consuming the control and 0.2% phosphate diet exhibited interstitial inflammation, tubular dilation, and cast formation, whereas KO mice receiving the 0.02% phosphate diet demonstrated less severe inflammation and tubular injury. (b) Glomerular injury scoring in KO mice fed either a control, 0.2%, or 0.02% phosphate diet (P=not significant (NS), n=3 per group for all measurements). (c) Tubulointerstitial injury index (see Materials and Methods) in KO mice fed a control, 0.2%, or 0.02% phosphate diet (*P<0.05). Kidney International 2013 84, 713-721DOI: (10.1038/ki.2013.194) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Chronic phosphate (phos) restriction leads to bone mineralization defects in Col4a3 mice. Micro-computed tomography (μCT) images of femurs from Col4a3 wild-type (WT) and Col4a3-null (KO) mice reveal a stepwise decrease in both cortical (a, b) and trabecular (c, d) bone mineral density with increased extent of phosphate restriction (n=6 per group; *P<0.05, **P<0.01, #P<0.001). (e) Bone ash studies of whole femurs from Col4a3 mice confirm that total mineral content is decreased in mice consuming phosphate-restricted diets (n=3 per group; *P<0.05, #P<0.001). NS, not significant. Kidney International 2013 84, 713-721DOI: (10.1038/ki.2013.194) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Changes in renal Cyp27b1 and Cyp24a1 expression in Col4a3 mice in response to chronic phosphate restriction. Kidney specimens from 8-week-old Col4a3-null (KO) and wild-type (WT) mice receiving either a control or 0.02% phosphate (phos) diet were analyzed by quantitative reverse transcription polymerase chain reaction for differences in Cyp27b1 and Cyp24a1 gene expression. (a) On the control diet, KO mice exhibited Cyp27b1 gene expression comparable to WT mice. Chronic phosphate restriction markedly increased Cyp27b1 gene expression in both KO and WT mice (*P<0.05, **P<0.01). (b) Cyp24a1 gene expression was 3.5-fold higher in KO mice compared with WT mice on the control diet (*P<0.05). Severe phosphate restriction suppressed Cyp24a1 gene expression to levels comparable to those observed in WT mice on the phosphate-deficient diet (**P<0.01; n≥5 per group for each analysis). Kidney International 2013 84, 713-721DOI: (10.1038/ki.2013.194) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Effect of phosphate restriction on renal klotho gene expression in Col4a3 mice. Kidney specimens from Col4a3-null (KO) and wild-type (WT) mice consuming the control and phosphate-restricted diets were analyzed by quantitative reverse transcription polymerase chain reaction for differences in klotho gene expression at (a) 8 weeks and (b) 12 weeks of age. At baseline, KO mice on a control diet exhibited 40% lower levels of klotho gene expression compared with WT littermates on the same diet at 8 weeks (P=0.06) and a 77% lower klotho gene expression by 12 weeks (P<0.001). Moderate phosphate (phos) restriction (0.2%) had no obvious impact on renal klotho gene expression in WT or KO mice at either 8 or 12 weeks of age. On the other hand, severe phosphate restriction (0.02%) was associated with a 60% greater renal klotho gene expression in WT mice at 8 weeks when compared with control diet WT mice (#P=0.001) and a twofold greater klotho gene expression in KO mice at 12 weeks in relation to control diet KO mice (*P=0.05). Despite an apparent increase in renal klotho gene expression in KO mice with severe phosphate restriction, klotho gene expression remained suppressed compared with WT mice on the same diet (P<0.01 for KO 0.02% phos vs. WT 0.02% phos; n≥4 per group for all groups). Kidney International 2013 84, 713-721DOI: (10.1038/ki.2013.194) Copyright © 2013 International Society of Nephrology Terms and Conditions